Dani Heba

home / authors / dani-heba

Dani Heba is a summer associate in Hunton’s New York office.

Articles

Semaglutide’s removal from the FDA shortages list sets the stage for more Novo Nordisk lawsuits

Armin Ghiam ;Dani Heba

August 18th 2025

Semaglutide faces renewed legal battles as Novo Nordisk targets compounding pharmacies for trademark infringement and false advertising after FDA shortage removal.

Latest Updated Articles

President Donald J. Trump © Courtesy of the Library of Congress Prints and Photographs Division

Published: March 3rd 2025 | Updated: April 3rd 2025

Trump tariffs on imports and effects on health care, explained

obesity bariatric surgery files: © Olivier Le Moal - stock.adobe.com

Published: January 27th 2025 | Updated: January 29th 2025

The Weight Loss Drug Revolution: GLP-1 RA drugs inspire new excitement for metabolic bariatric surgeons

semaglutide weight loss concept: © millaf - stock.adobe.com

Published: January 27th 2025 | Updated: January 29th 2025

The Weight Loss Drug Revolution: Helping patients avoid phony medicine scams

96th annual Medical Economics Physician Report

Published: August 7th 2025 | Updated: August 18th 2025

Exclusive data on physician pay, practice finance, top challenges and more

Mark McClellan, M.D., Ph.D., director, Duke-Margolis Institute for Health Policy, former CMS administrator

Published: August 4th 2025 | Updated: August 18th 2025

10 years in: The impact of value-based care

Published: April 3rd 2025 | Updated: August 18th 2025

Trump tariffs will raise prices: Learn how to cut costs, grow revenue at your practice

Contributor Guidelines

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777